{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:05:07Z","timestamp":1787879107288,"version":"build-2784847793"},"reference-count":16,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T00:00:00Z","timestamp":1741478400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"DOI":"10.2340\/actadv.v105.42987","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T06:40:01Z","timestamp":1741588801000},"page":"adv42987","source":"Crossref","is-referenced-by-count":1,"title":["Multiple Biologics Treatment Failures in Patients with Psoriasis: A Case Series of 4 Patients"],"prefix":"10.2340","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2442-5735","authenticated-orcid":false,"given":"Mikkel Bak","family":"Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2950-3280","authenticated-orcid":false,"given":"Nikolai","family":"Loft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5506-1319","authenticated-orcid":false,"given":"Claus","family":"Zachariae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4784-9680","authenticated-orcid":false,"given":"Lone","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2025,3,9]]},"reference":[{"key":"100101","doi-asserted-by":"crossref","unstructured":"Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020; 369: m1590.","DOI":"10.1136\/bmj.m1590"},{"key":"100102","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/bmj.m1590","DOI":"10.1136\/bmj.m1590"},{"key":"100103","doi-asserted-by":"crossref","unstructured":"Loft N, Egeberg A, Rasmussen MK, et al. Prevalence and characterization of treatment\u2010refractory psoriasis and super\u2010responders to biologic treatment: a nationwide study. J Eur Acad Dermatol Venereol 2022; 36: 1284-1291.","DOI":"10.1111\/jdv.18126"},{"key":"100104","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.18126","DOI":"10.1111\/jdv.18126"},{"key":"100105","doi-asserted-by":"crossref","unstructured":"Mason KJ, Alabas OA, Dand N, et al. Characteristics of 'super responders' and 'super nonresponders' to first biologic monotherapy for psoriasis: a nested case-control study. Br J Dermatol 2024; 190: 441-444.","DOI":"10.1093\/bjd\/ljad446"},{"key":"100106","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/bjd\/ljad446","DOI":"10.1093\/bjd\/ljad446"},{"key":"100107","doi-asserted-by":"crossref","unstructured":"van Vugt LJ, van den Reek JMPA, Coenen MJH, de Jong EMGJ. A systematic review of pharmacogenetic studies on the response to biologics in patients with psoriasis. Br J Dermatol 2018; 178: 86-94.","DOI":"10.1111\/bjd.15753"},{"key":"100108","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.15753","DOI":"10.1111\/bjd.15753"},{"key":"100109","doi-asserted-by":"crossref","unstructured":"Hjort G, Schwarz CW, Skov L, Loft N. Clinical Characteristics Associated With Response to Biologics in the Treatment of Psoriasis. JAMA Dermatol 2024; 160: 830-837.","DOI":"10.1001\/jamadermatol.2024.1677"},{"key":"100110","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jamadermatol.2024.1677","DOI":"10.1001\/jamadermatol.2024.1677"},{"key":"100111","doi-asserted-by":"crossref","unstructured":"Schwarz CW, Loft N, Rasmussen MK, et al. Predictors of response to biologics in patients with moderate-to-severe psoriasis: a Danish nationwide cohort study. Acta Derm Venereol 2021; 101: adv00579.","DOI":"10.2340\/actadv.v101.351"},{"key":"100112","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2340\/actadv.v101.351","DOI":"10.2340\/actadv.v101.351"},{"key":"100113","doi-asserted-by":"crossref","unstructured":"Bokor-Billmann T, Sch\u00e4kel K. No need to change the drug class: ixekizumab- following secukinumab-therapy in psoriasis. J Dermatolog Treat 2019; 30: 216-220.","DOI":"10.1080\/09546634.2018.1506081"},{"key":"100114","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/09546634.2018.1506081","DOI":"10.1080\/09546634.2018.1506081"},{"key":"100115","doi-asserted-by":"crossref","unstructured":"Yiu ZZN, Mason KJ, Hampton PJ, Reynolds NJ, Smith CH, Lunt M, et al. Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). Br J Dermatol 2020; 183: 294-302.","DOI":"10.1111\/bjd.18981"},{"key":"100116","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.18981","DOI":"10.1111\/bjd.18981"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/42987\/49446","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/42987\/49446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T06:40:10Z","timestamp":1741588810000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/42987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,9]]},"references-count":16,"URL":"https:\/\/doi.org\/10.2340\/actadv.v105.42987","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,9]]}}}